PriceTargets.com logo

Lifeward - LFWD Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $6.17
  • Forecasted Upside: 780.95%
  • Number of Analysts: 4
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$0.70 As of 12/4/2025 05:00 PM ET
▲ +0.01 (1.45%)

This chart shows the closing price for LFWD by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Lifeward Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for LFWD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for LFWD

Analyst Price Target is $6.17
▲ +780.95% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Lifeward in the last 3 months. The average price target is $6.17, with a high forecast of $10.00 and a low forecast of $4.00. The average price target represents a 780.95% upside from the last price of $0.70.

This chart shows the closing price for LFWD for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 4 contributing investment analysts is to moderate buy stock in Lifeward. This rating has held steady since September 2025, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2024
  • 1 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2024
  • 1 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
11/4/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/18/2025HC WainwrightLower TargetBuy ➝ Buy$13.00 ➝ $4.50
10/8/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
9/27/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
3/11/2025Lake Street CapitalLower TargetBuy ➝ Buy$4.50 ➝ $4.00
3/11/2025HC WainwrightReiterated RatingBuy ➝ Buy$13.00 ➝ $13.00
2/20/2025Lake Street CapitalLower TargetBuy ➝ Buy$6.00 ➝ $4.50
2/20/2025HC WainwrightReiterated RatingBuy ➝ Buy$13.00 ➝ $13.00
2/10/2025LaidlawInitiated CoverageBuy$10.00
11/13/2024HC WainwrightReiterated RatingBuy ➝ Buy$13.00 ➝ $13.00
8/16/2024HC WainwrightBoost TargetBuy ➝ Buy$9.00 ➝ $13.00
6/24/2024Lake Street CapitalUpgradeStrong-Buy
5/16/2024HC WainwrightBoost TargetBuy ➝ Buy$9.00 ➝ $13.00
4/15/2024HC WainwrightReiterated RatingBuy ➝ Buy$9.00
2/28/2024HC WainwrightReiterated RatingBuy ➝ Buy$21.00
(Data available from 12/5/2020 forward)

News Sentiment Rating

0.42 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/9/2025
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/8/2025
  • 0 very positive mentions
  • 12 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/8/2025
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/7/2025
  • 2 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/6/2025
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/6/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/5/2025
  • 2 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/5/2025

Current Sentiment

  • 2 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Lifeward logo
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.
Read More

Today's Range

Now: $0.70
Low: $0.65
High: $0.75

50 Day Range

MA: $0.65
Low: $0.52
High: $0.83

52 Week Range

Now: $0.70
Low: $0.50
High: $4.00

Volume

2,262,769 shs

Average Volume

706,233 shs

Market Capitalization

$12.80 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.01

Frequently Asked Questions

What sell-side analysts currently cover shares of Lifeward?

The following sell-side analysts have issued reports on Lifeward in the last twelve months: HC Wainwright, Laidlaw, Lake Street Capital, and Weiss Ratings.
View the latest analyst ratings for LFWD.

What is the current price target for Lifeward?

0 Wall Street analysts have set twelve-month price targets for Lifeward in the last year. Their average twelve-month price target is $6.17, suggesting a possible upside of 781.0%. Laidlaw has the highest price target set, predicting LFWD will reach $10.00 in the next twelve months. Lake Street Capital has the lowest price target set, forecasting a price of $4.00 for Lifeward in the next year.
View the latest price targets for LFWD.

What is the current consensus analyst rating for Lifeward?

Lifeward currently has 1 sell rating and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for LFWD.

What other companies compete with Lifeward?

Other companies that are similar to Lifeward include Jin Medical International, electroCore, SurgePays, PetVivo and Zynex. Learn More about companies similar to Lifeward.

How do I contact Lifeward's investor relations team?

Lifeward's physical mailing address is 3 Hatnufa Street, Floor 6, Yokneam Illit 2069203, Israel. The company's listed phone number is 972-4-959-0123 and its investor relations email address is [email protected]. The official website for Lifeward is www.rewalk.com. Learn More about contacing Lifeward investor relations.